AU2018900409A0 - Treatment of respiratory infection (3) - Google Patents

Treatment of respiratory infection (3)

Info

Publication number
AU2018900409A0
AU2018900409A0 AU2018900409A AU2018900409A AU2018900409A0 AU 2018900409 A0 AU2018900409 A0 AU 2018900409A0 AU 2018900409 A AU2018900409 A AU 2018900409A AU 2018900409 A AU2018900409 A AU 2018900409A AU 2018900409 A0 AU2018900409 A0 AU 2018900409A0
Authority
AU
Australia
Prior art keywords
treatment
respiratory infection
respiratory
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900409A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axelia Oncology Pty Ltd
Original Assignee
Ena Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Ena Therapeutics Pty Ltd filed Critical Ena Therapeutics Pty Ltd
Publication of AU2018900409A0 publication Critical patent/AU2018900409A0/en
Priority to PCT/AU2018/050295 priority Critical patent/WO2018176099A1/en
Priority to CN201880020768.1A priority patent/CN110461351B/en
Priority to JP2019552871A priority patent/JP2020512336A/en
Priority to AU2018241248A priority patent/AU2018241248A1/en
Priority to US16/495,829 priority patent/US20200147028A1/en
Priority to EP18774987.4A priority patent/EP3600374B1/en
Priority to JP2023034511A priority patent/JP2023081969A/en
Abandoned legal-status Critical Current

Links

AU2018900409A 2017-03-31 2018-02-09 Treatment of respiratory infection (3) Abandoned AU2018900409A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PCT/AU2018/050295 WO2018176099A1 (en) 2017-03-31 2018-03-29 Treatment of respiratory infection with a tlr2 agonist
CN201880020768.1A CN110461351B (en) 2017-03-31 2018-03-29 Treatment of respiratory tract infections with TLR2 agonists
JP2019552871A JP2020512336A (en) 2017-03-31 2018-03-29 Treatment of respiratory infections with TLR agonists
AU2018241248A AU2018241248A1 (en) 2017-03-31 2018-03-29 Treatment of respiratory infection with a TLR2 agonist
US16/495,829 US20200147028A1 (en) 2017-03-31 2018-03-29 Treatment of respiratory infection with a tlr2 agonist
EP18774987.4A EP3600374B1 (en) 2017-03-31 2018-03-29 Treatment of respiratory infection
JP2023034511A JP2023081969A (en) 2017-03-31 2023-03-07 Treatment of respiratory infection with tlr agonist

Publications (1)

Publication Number Publication Date
AU2018900409A0 true AU2018900409A0 (en) 2018-02-22

Family

ID=

Similar Documents

Publication Publication Date Title
EP3490987A4 (en) Novel therapeutic agents for the treatment of hbv infection
EP3621973A4 (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3846846A4 (en) Compositions and methods for the treatment of viral infections
EP3790563A4 (en) Compositions for the treatment of skin conditions
EP3784260A4 (en) Compositions for the treatment of skin conditions
EP3969597A4 (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3927428A4 (en) Methods of treatment of respiratory disorders
EP3458045A4 (en) Treatment of meniere's disease
EP3773659A4 (en) Methods for treatment of hbv infection
EP3813872A4 (en) Compositions for the treatment of skin conditions
EP3619204A4 (en) Compounds for the treatment of respiratory diseases
EP3634583A4 (en) Long-action implant for treatment of infectious diseases
EP3877383A4 (en) Compounds and compositions for the treatment of respiratory diseases
EP3866601A4 (en) Organosilanes for the treatment of infections
EP3856213A4 (en) Methods of treatment of infections using bacteria
EP3911160A4 (en) Treatment of plants against disease
EP3789019A4 (en) Composition for prevention or treatment of skin infection
EP3761982A4 (en) Treatment of demyelinating diseases
AU2018900409A0 (en) Treatment of respiratory infection (3)
EP3856747C0 (en) Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection
AU2017905124A0 (en) Treatment of respiratory infection (2)
EP3935074A4 (en) Isthmin 1 for treatment of lung inflammation
EP3834761A4 (en) Medical treatment instrument
EP3761981A4 (en) Treatment of demyelinating diseases
EP3846843A4 (en) Compositions and methods for the treatment of heart disease